(2/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities

(2/3) MMC、VICC 和 TSU：消除癌症差异的合作伙伴

• 批准号: 10328032
• 负责人: Tuya Pal
• 金额: $ 155.05万
• 依托单位: VANDERBILT UNIVERSITY MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-21 至 2026-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10328032
• 关键词: Address; Area; Award; Awareness; Basic Science; Behavioral; Big Data; Bioinformatics; Bioinformatics Shared Resource; Biological Factors; Biometry; Cancer Center; Cancer Patient; Cancer Research Project; Clinical Research; Clinical Sciences; Clinical Trials; Collaborations; Colorectal Cancer; Communities; Community Health; Comprehensive Cancer Center; Development; Discipline; Education; Effectiveness; Environment; Ethnic Origin; Evaluation; Extramural Activities; Faculty; Financial Hardship; Fostering; Geographic Locations; Geography; Goals; Growth; Health Educators; Healthcare; Immunooncology; Incidence; Infrastructure; Institution; Intervention Trial; Lead; Malignant Neoplasms; Malignant neoplasm of lung; Malignant neoplasm of prostate; Medical Students; Minority; Minority-Serving Institution; Mission; Oncology; Outcome; Pathology; Pathway interactions; Patient Participation; Peer Review; Population Research; Population Sciences; Prevalence; Publications; Race; Research; Research Infrastructure; Research Personnel; Research Project Grants; Research Training; Resource Sharing; Series; Tennessee; Training; Translational Research; Triad Acrylic Resin; Underrepresented Minority; United States; Universities; anticancer research; base; cancer clinical trial; cancer health disparity; career; collaborative approach; community based participatory research; community organizations; education research; evidence base; graduate student; health care disparity; health disparity; high school; malignant breast neoplasm; medical schools; minority communities; mortality; multidisciplinary; outreach; outreach program; programs; recruit; screening; socioeconomics; survivorship; treatment trial; undergraduate student; underserved community

PROJECT SUMMARY: OVERALL Cancer health disparities based on factors such as race and ethnicity are the result of a combination of socioeconomic, environmental, behavioral, and biological factors. These disparities impact cancer incidence, prevalence, mortality, survivorship, financial burden, and screening rates. The long-standing and mature Meharry Medical College (MMC), Vanderbilt-Ingram Cancer Center (VICC), Tennessee State University (TSU) Cancer Partnership (MVTCP), continues to provide and expand upon an exceptional cancer research and training environment to support the efforts of diverse investigators in addressing disparities. These efforts span across multiple disciplines to study the determinants of cancer health disparities at an NCI-designated comprehensive cancer center (VICC) along with enhancing research infrastructure, capacity-building, and impact at two minority- serving institutions (MMC and TSU). Collectively, over the past twenty years of partnership, these collaborative efforts provide a robust infrastructure to address and overcome cancer disparities while expanding research opportunities, recruitment and training. Our Triad has benefited from sustained and strong collaborative interactions between the three partner institutions, resulting in robust community and educational outcomes. Moreover, the geographical placement of this Triad in Tennessee, a region with some of the highest cancer incidence and mortality rates in the United States, also provides a unique opportunity for our Partnership to positively impact outcomes for cancer patients in this geographical region. This region continues to have significant cancer health disparities in lung, breast, prostate, and colorectal cancers. In order to meet our ultimate goals of overcoming cancer disparities while simultaneously strengthening research impact, the overall objectives of this competing renewal application are to: 1) increase the participation in traditional, investigator- initiated cancer research projects awarded to MMC and TSU faculty with collaborative guidance by senior VICC faculty; 2) increase the number of investigator-initiated awards to VICC junior faculty that address cancer disparities; 3) recruit, train and retain early-stage investigators to become independent leaders in cancer health disparities and cancer research and training; 4) expand MVTCP participation in national oncology treatment and interventional trials; 5) strengthen the physical and intellectual infrastructure for research at MMC and TSU; 6) facilitate partnerships between community organizations and academic researchers, leading to hypothesis- driven research projects that include the involvement of a community health educator; 7) increase the number of MMC and TSU trainees engaged in cancer research; and 8) increase awareness of cancer research opportunities and careers for minority high school, undergraduate, graduate and medical students through the Pathway to Discovery program.

项目概要：总体 基于种族和民族等因素的癌症健康差异是多种因素共同作用的结果 社会经济、环境、行为和生物因素。这些差异影响癌症发病率， 患病率、死亡率、生存率、经济负担和筛查率。历史悠久、成熟的梅哈里 医学院 (MMC)、范德比尔特-英格拉姆癌症中心 (VICC)、田纳西州立大学 (TSU) 癌症 合作伙伴关系 (MVTCP)，继续提供并扩展卓越的癌症研究和培训 支持不同调查人员努力解决差异的环境。这些努力涵盖 多个学科在 NCI 指定的综合性研究机构中研究癌症健康差异的决定因素 癌症中心 (VICC)，同时加强研究基础设施、能力建设和对两个少数群体的影响 服务机构（MMC 和 TSU）。总的来说，在过去二十年的合作中，这些合作 这些努力为解决和克服癌症差异提供了强大的基础设施，同时扩大了研究范围 机会、招聘和培训。我们的三合会受益于持续和强有力的合作 三个合作机构之间的互动，产生了强有力的社区和教育成果。 此外，这个三合会的地理位置位于田纳西州，该地区是癌症发病率最高的地区 美国的发病率和死亡率，也为我们的伙伴关系提供了一个独特的机会 对该地理区域的癌症患者的治疗结果产生积极影响。该地区继续有 肺癌、乳腺癌、前列腺癌和结直肠癌的癌症健康状况存在显着差异。为了满足我们的终极 克服癌症差异的目标，同时加强研究影响，总体 这一竞争性更新申请的目标是：1）增加传统的、研究者的参与 在高级 VICC 的协作指导下，发起了授予 MMC 和 TSU 教员的癌症研究项目 学院; 2) 增加研究者向 VICC 初级教师发起的癌症研究奖励数量 差异； 3) 招募、培训和留住早期研究人员，使其成为癌症健康领域的独立领导者 差异以及癌症研究和培训； 4) 扩大 MVTCP 对国家肿瘤治疗的参与； 介入试验； 5) 加强 MMC 和 TSU 研究的物理和智力基础设施； 6） 促进社区组织和学术研究人员之间的伙伴关系，从而产生假设- 推动研究项目，其中包括社区健康教育者的参与； 7）增加数量 从事癌症研究的 MMC 和 TSU 学员； 8) 提高对癌症研究的认识 通过以下方式为少数族裔高中生、本科生、研究生和医学院学生提供机会和职业 探索之路计划。